How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q2 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
How Will Ozempic and Wegovy Sales Aid NVO’s Upcoming Q2 Results?
Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…
Oral Wegovy FDA Win Reframes Novo Nordisk Growth And Longevity Story
Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge. Novo…
European medicines regulator recommends approval for Novo’s Wegovy pill
May 22 (Reuters) – The European Medicines Agency recommended approval for Novo Nordisk’s weight-loss pill Wegovy, the regulator…
European medicines regulator recommends approval for Novo’s Wegovy pill
Fri, May 22, 2026 at 10:51 AM UTC FILE PHOTO: The logo of pharmaceutical company Novo Nordisk is…
Here’s Why Agios Pharmaceuticals Crashed 23% Today
Key Points Agios Pharmaceuticals shares dropped 23% following Novo Nordisk’s trial results. Novo’s etavopivat outperformed Agios’ mitapavit in…
Novo Nordisk Ups the Ante with Wegovy HD Rollout
In a significant development for the weight-loss drug market, Novo Nordisk has introduced a higher-dose version of…
Novo Nordisk wins FDA approval for Awiqli insulin | NVO SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 6-K ________________ REPORT…
Novo Nordisk wins FDA approval for Wegovy HD | NVO SEC Filing
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________ FORM 6-K ________________ REPORT…
Is Novo Nordisk’s Turnaround Story at Risk After Weak 2026 Outlook?
Novo Nordisk NVO announced better-than-expected fourth-quarter and full-year results last week. The company is a dominant player in the cardiometabolic…